MX2021014578A - Azepinas como moduladores del ensamblaje de la cápside del vhb. - Google Patents

Azepinas como moduladores del ensamblaje de la cápside del vhb.

Info

Publication number
MX2021014578A
MX2021014578A MX2021014578A MX2021014578A MX2021014578A MX 2021014578 A MX2021014578 A MX 2021014578A MX 2021014578 A MX2021014578 A MX 2021014578A MX 2021014578 A MX2021014578 A MX 2021014578A MX 2021014578 A MX2021014578 A MX 2021014578A
Authority
MX
Mexico
Prior art keywords
azepines
capsid assembly
hbv capsid
assembly modulators
modulators
Prior art date
Application number
MX2021014578A
Other languages
English (en)
Inventor
Scott D Kuduk
Original Assignee
Janssen Sciences Ireland Unlimited Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland Unlimited Co filed Critical Janssen Sciences Ireland Unlimited Co
Publication of MX2021014578A publication Critical patent/MX2021014578A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se divulgan compuestos, composiciones y métodos para tratar enfermedades, síndromes, afecciones y trastornos que se ven afectados por la modulación de CAM1; tales compuestos se representan mediante la Fórmula (I) tal como sigue: (ver fórmula) en donde R1 , R2 , R3 , R4 , X e Y se definen en la presente.
MX2021014578A 2019-05-28 2020-05-27 Azepinas como moduladores del ensamblaje de la cápside del vhb. MX2021014578A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962853556P 2019-05-28 2019-05-28
PCT/EP2020/064746 WO2020239861A1 (en) 2019-05-28 2020-05-27 Azepines as hbv capsid assembly modulators

Publications (1)

Publication Number Publication Date
MX2021014578A true MX2021014578A (es) 2022-03-17

Family

ID=70968927

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021014578A MX2021014578A (es) 2019-05-28 2020-05-27 Azepinas como moduladores del ensamblaje de la cápside del vhb.

Country Status (10)

Country Link
US (1) US20220251114A1 (es)
EP (1) EP3976613A1 (es)
JP (1) JP2022534961A (es)
KR (1) KR20220015421A (es)
CN (1) CN113891890A (es)
AU (1) AU2020281802A1 (es)
BR (1) BR112021023651A2 (es)
CA (1) CA3138149A1 (es)
MX (1) MX2021014578A (es)
WO (1) WO2020239861A1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017008720A (es) * 2014-12-30 2018-01-25 Novira Therapeutics Inc Derivados y metodos para tratamiento de las infecciones por hepatitis b.
US10875876B2 (en) * 2015-07-02 2020-12-29 Janssen Sciences Ireland Uc Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
CN114057739A (zh) * 2016-06-29 2022-02-18 诺维拉治疗公司 二氮杂酮衍生物及其在治疗乙型肝炎感染中的用途

Also Published As

Publication number Publication date
CA3138149A1 (en) 2020-12-03
CN113891890A (zh) 2022-01-04
BR112021023651A2 (pt) 2022-04-12
AU2020281802A1 (en) 2021-11-25
EP3976613A1 (en) 2022-04-06
JP2022534961A (ja) 2022-08-04
KR20220015421A (ko) 2022-02-08
WO2020239861A1 (en) 2020-12-03
US20220251114A1 (en) 2022-08-11

Similar Documents

Publication Publication Date Title
MX2022005827A (es) Derivados de pirazol como inhibidores de malt1.
PH12021551167A1 (en) New heterocyclic compounds
MX2021013193A (es) Cicloalquilos sustituidos como moduladores de la vía integrada del estrés.
JO2853B1 (en) Sulfonamides as TRPM8 organizations
MX2021013197A (es) Cicloalquilos sustituidos como moduladores de la vía integrada del estrés.
MX2021014350A (es) Compuestos de 1-oxo-isoindolin-5-carboxamida sustituida, composiciones de los mismos y metodos de tratamiento con los mismos.
PH12020552207A1 (en) Pyrazole derivatives as malt1 inhibitors
EA202092248A1 (ru) Замещенные соединения 4-аминоизоиндолин-1,3-диона, их композиции и способы лечения ими
MX2020006290A (es) Dinucleotidos ciclicos como agonistas de sting.
MX2021009521A (es) Inhibidores de dihidroorotato deshidrogenasa.
PH12020552206A1 (en) Pyrazole derivatives as malt1 inhibitors
MX2021012706A (es) Inhibidores de dihidroorotato deshidrogenasa.
WO2010124121A8 (en) Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor
PH12017502009A1 (en) Novel sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
MX2021001565A (es) Inhibidores tipo indol y azaindol de enzimas peptidil arginina deiminasas (pad).
PH12020552172A1 (en) Cyclic dinucleotides as sting agonists
EA202190272A1 (ru) Дополнительно замещенные производные триазолохиноксалина
CR20220004A (es) Nuevos compuestos heterocíclicos
EA202190271A1 (ru) Замещенные триазолохиноксалиновые производные
MX2020013827A (es) Proceso de preparacion de compuestos triciclicos.
MX2021014578A (es) Azepinas como moduladores del ensamblaje de la cápside del vhb.
MX2021014580A (es) Derivados heterociclos condensados como moduladores de ensamblaje de la capside.
CR20220006A (es) Compuestos para tratar enfermedad respiratoria
MX2021014577A (es) Difluoroazepanos como moduladores del ensamblaje de la cápside del vhb.
MX2021012417A (es) Anillos de piridina que contienen derivados como inhibidores de malt1.